Akron Bio unveils gene therapy, vaccine manufacturing facility

By The Science Advisory Board staff writers

April 19, 2022 -- Akron Bio has established a new current good manufacturing practice (cGMP) facility in Sarasota, FL to enhance its plasmid DNA production capabilities. The facility will reinforce Akron Bio’s place in the cell and gene therapy development space, as plasmid DNA is a major component used in the assembly of many treatments in this therapeutic field.

By using cGMP standards and safety measures, the facility will supply resources needed for the cell and gene therapy market in alignment with Akron Bio's expertise in ancillary biomaterial manufacturing.


Copyright © 2022 scienceboard.net
 


Email Address:

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.